Jeffrey Farrow, CFO at Hyperion Therapeutics, holds 26.74K shares in Global Blood Therapeutics (Ticker: GBT), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds ― shares in Tarsus Pharmaceuticals (Ticker: TARS). Most recently, Jeffrey Farrow Bought ― shares of Global Blood Therapeutics on Sep 29, 2022 for an estimated value of 387.91K.